Universal Biosensors Changes Certifying Accountant
| Field | Detail |
|---|---|
| Company | Universal Biosensors Inc |
| Form Type | 8-K |
| Filed Date | Nov 17, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, accounting
TL;DR
Universal Biosensors dumped PwC, new auditor TBD.
AI Summary
Universal Biosensors, Inc. announced on November 14, 2025, that it has changed its certifying accountant. The company's previous accountant was PwC, and the new accountant is not yet specified in this filing. This change is effective as of November 14, 2025.
Why It Matters
A change in a company's auditor can sometimes signal underlying issues or a strategic shift, and investors will want to understand the reasons behind this decision.
Risk Assessment
Risk Level: medium — A change in auditor, especially without immediate disclosure of the replacement, can sometimes indicate disagreements or concerns that warrant further investigation.
Key Players & Entities
- Universal Biosensors, Inc. (company) — Registrant
- PwC (company) — Previous certifying accountant
- November 14, 2025 (date) — Effective date of change
FAQ
When was the change in certifying accountant effective?
The change in certifying accountant was effective as of November 14, 2025.
Who was Universal Biosensors, Inc.'s previous certifying accountant?
Universal Biosensors, Inc.'s previous certifying accountant was PwC.
Has a new certifying accountant been appointed yet?
This filing does not specify the name of the new certifying accountant.
What is the company's principal executive office address?
The address of the principal executive offices is 1 Corporate Avenue, Rowville, Victoria, Australia, 3178.
What is the company's telephone number?
The company's telephone number is +61 3 9213 9000.
Filing Stats: 675 words · 3 min read · ~2 pages · Grade level 13.8 · Accepted 2025-11-14 19:42:40
Filing Documents
- 8-k_pwcresignat.htm (8-K) — 24KB
- pwcresponsetoitem4.01.htm (EX-16.1) — 2KB
- 0001279695-25-000006.txt ( ) — 28KB
01. Changes in Registrant's Certifying Accountant
Item 4.01. Changes in Registrant's Certifying Accountant On November 14, 2025, PricewaterhouseCoopers ("PwC") resigned as the independent registered public accounting firm of Universal Biosensors, Inc. (the "Company"). A new independent accountant has not been engaged as the Company is ceasing operations, has entered into receivership, and intends to promptly deregister its securities. PwC's report on the Company's financial statements as of and for the fiscal years ended December 31, 2024 and 2023 did not contain any adverse opinion or disclaimer of opinion, nor was it qualified or modified as to uncertainty, audit scope, or accounting principles, except that PwC's report for the fiscal year ended December 31, 2024 included an explanatory paragraph indicating that there was substantial doubt about the Company's ability to continue as a going concern. During the fiscal years ended December 31, 2024 and 2023 and the subsequent interim period through November 14, 2025, there were (i) no "disagreements" (as that term is defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) between the Company and PwC on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of PwC, would have caused PwC to make reference to the subject matter of the disagreement in its reports on the Company's consolidated financial statements and (ii) no "reportable events" (as that term is defined in Item 304(a)(1)(v) of Regulation S-K and the related instructions). The Company provided PwC with a copy of this Current Report on Form 8-K and requested that PwC furnish to the Company a letter addressed to the United States Securities and Exchange Commission ("SEC") stating whether or not PwC agrees with the above statements and, if not, stating the respects in which it does not agree. A copy of PwC's letter to the SEC, dated November 14, 2025, is attached as
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description of Exhibits
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. UNIVERSAL BIOSENSORS, INC. Date: November 14, 2025 By: /s/ Peter Mullin Peter Mullin CEO & Corporate Secretary